Direct answer
Direct answer: Tenet Healthcare's earnings are driven by two structurally different businesses. The Ambulatory Care segment through USPI produces approximately 39% adjusted EBITDA margins from elective outpatient surgery at ambulatory surgery centers, where commercial payer mix is favorable and fixed costs are low. The Hospital Operations segment produces approximately 18% adjusted EBITDA margins from inpatient and outpatient care at acute-care hospitals, where payer mix is broader and labor costs are higher. In Q2 2026, consolidated adjusted EBITDA reached $1.304 billion, up 16.3%, on $5.628 billion in net operating revenue. Full-year 2026 guidance calls for $4.83 to $5.03 billion in adjusted EBITDA and $2.725 to $3.025 billion in adjusted free cash flow.
Q2 2026 results
Tenet Healthcare reported its second-quarter 2026 results with strong growth across both adjusted earnings and free-cash-flow guidance. The table below summarizes the key reported figures.
| Metric | Q2 2026 | Notes |
|---|---|---|
| Net operating revenue | $5.628 billion | Consolidated |
| Net income (available to common shareholders) | $826 million | GAAP |
| Diluted EPS (GAAP) | $9.84 | |
| Adjusted EPS | $6.12 | +52.2% year over year |
| Consolidated adjusted EBITDA | $1.304 billion | +16.3% year over year |
| Adjusted EBITDA margin | 23.2% | Consolidated |
The 52.2% increase in adjusted EPS is notable. Part of this reflects improved operating performance, and part may reflect the effect of share repurchases reducing the diluted share count. Investors should separate organic earnings growth from per-share earnings growth driven by buybacks when assessing the underlying business trajectory. Both are relevant, but they tell different stories: operating earnings growth tells you about the business, and per-share growth tells you about the return per unit of equity.
The GAAP diluted EPS of $9.84 versus adjusted EPS of $6.12 reflects the impact of one-time items or non-recurring charges excluded from the adjusted figure. Healthcare companies regularly report both. Investors should review the company's reconciliation table in the press release to understand what is excluded from the adjusted figure and whether those exclusions are recurring in character.
Segment performance: Hospital Operations vs. Ambulatory Care
The two-segment structure is the most important analytical framework for Tenet. The segments have different growth rates, margin profiles, competitive dynamics, and capital intensity. Blending them into a single consolidated view obscures the most important differences.
| Segment metric | Hospital Operations Q2 2026 | Ambulatory Care Q2 2026 |
|---|---|---|
| Revenue | $4.240 billion (+6% YoY) | $1.388 billion (+9.3% YoY) |
| Adjusted EBITDA | $762 million (+22.3% YoY) | $542 million (+8.8% YoY) |
| Adjusted EBITDA margin | 18.0% (vs. 15.6% prior year) | 39.0% |
| Same-facility revenue growth | Not separately disclosed | +5.0% (system-wide patient-service revenue) |
| Volume indicator | Adjusted admissions (not disclosed in this summary) | Cases: -1.2% |
| Pricing / mix indicator | Revenue per adjusted admission (not disclosed here) | Net revenue per case: +6.3% |
Hospital Operations analysis
The 22.3% growth in Hospital Operations adjusted EBITDA on 6% revenue growth is the standout result in Q2 2026. A business with operating leverage that large is either benefiting from cost reductions, favorable timing of supplemental payments, an improvement in payer mix, or some combination. The 240 basis point improvement in margin from 15.6% to 18.0% applied to $4.240 billion in quarterly revenue is approximately $100 million in incremental quarterly EBITDA. Sustaining that margin level, or improving further toward the mid-20s range common at higher-performing hospital systems, is the central hypothesis for the hospital business going forward.
Labor is the variable to watch most closely. Hospital operations are labor-intensive: nurses, physicians, therapists, and clinical staff represent roughly 45 to 50 percent of net operating revenue. During 2022 and 2023, the U.S. healthcare industry faced a severe labor shortage that drove contract travel-nurse usage to record levels, with contract labor premiums representing 300 to 500 basis points of margin headwind at many systems. The normalization of contract labor rates is likely a contributing factor to the Hospital Operations margin improvement in Q2 2026.
Ambulatory Care analysis
The Ambulatory segment's 39.0% adjusted EBITDA margin is exceptional by hospital-company standards. It reflects three structural advantages: a higher commercial payer mix (elective outpatient surgery patients disproportionately carry commercial insurance), lower fixed-cost infrastructure per procedure compared to acute hospitals, and the ability to scale case volume without proportionally scaling the fixed-cost base.
The Q2 2026 data shows a case volume decline of 1.2% offset by 6.3% growth in net revenue per case. Higher revenue per case driven by procedure mix and payer mix improvement is a sustainable source of growth if it reflects a genuine shift toward more complex, higher-reimbursed procedures. The net result was same-facility system-wide revenue growth of 5.0%, healthy enough to sustain EBITDA growth of 8.8% given margin stability. Investors should watch whether case volume returns to growth or whether the volume softness is structural.
Key metrics to watch each quarter
The following metrics drive the majority of Tenet's financial performance variation from quarter to quarter. Investors who track these figures consistently will have the context needed to evaluate each new quarter's results.
| Metric | Segment | Signal when rising | Signal when falling |
|---|---|---|---|
| Same-facility ambulatory revenue (system-wide) | Ambulatory Care | Organic growth in the highest-margin business | Possible volume loss to competitors or procedure-mix shift |
| Net revenue per case | Ambulatory Care | Higher acuity, better payer mix, favorable procedure mix | Pricing pressure, payer mix deterioration |
| Ambulatory EBITDA less NCI | Ambulatory Care | Growing cash earnings attributable to Tenet shareholders | NCI dilution growing faster than segment earnings |
| Hospital adjusted admissions | Hospital Operations | Volume health of hospital network | Volume loss, potential fixed-cost deleverage |
| Hospital revenue per adjusted admission | Hospital Operations | Pricing, payer mix, and service intensity improving | Payer mix worsening, rate pressure |
| Hospital adjusted EBITDA margin | Hospital Operations | Operating leverage on fixed cost base | Labor cost pressure, supplemental payment decline |
| Commercial payer percentage | Both | Higher commercial rates support both segments | Medicaid expansion or economic weakness shifts mix |
| Contract labor as percentage of revenue | Hospital Operations | Lower contract labor indicates normalizing labor market | Elevated travel-nurse usage signals margin headwind |
| Adjusted free cash flow | Consolidated | Capital-return capacity; debt-reduction ability | Suggests working capital or capex headwind |
| Net debt / adjusted EBITDA | Consolidated | Leverage declining; financial flexibility improving | Leverage rising; potential covenant or refinancing risk |
Full-year 2026 guidance
Following Q2 2026 results, Tenet management raised its full-year 2026 financial outlook. The updated guidance is as follows:
| Metric | Updated Full-Year 2026 Guidance |
|---|---|
| Adjusted EBITDA | $4.83 to $5.03 billion |
| Adjusted free cash flow | $2.725 to $3.025 billion |
| Share-repurchase authorization (increase) | $2 billion (board approved) |
The midpoint of the adjusted EBITDA guidance range, $4.93 billion, represents a meaningful increase from prior guidance and reflects management's confidence in the sustainability of Q2 margins. At the midpoint of the free-cash-flow guidance ($2.875 billion), Tenet is guiding to one of the strongest cash-generation periods in its recent history.
Guidance should be treated as a management estimate, not a commitment. Healthcare-company guidance is subject to supplemental payment timing, payer-mix fluctuations, labor market conditions, and unexpected volume changes. The degree to which actual results track guidance over several quarters is informative about management's operational visibility and forecasting discipline.
The $2 billion share-repurchase expansion signals that management views the stock as attractively priced relative to free cash flow generation and believes capital returned to shareholders will exceed the return available from incremental hospital or ASC acquisitions at current market prices. Whether that judgment proves correct depends on what the stock trades for relative to intrinsic value, which is a separate analytical question from the business's earnings trajectory.
Frequently asked questions
What were Tenet Healthcare's Q2 2026 financial results?
Tenet Healthcare reported Q2 2026 net operating revenue of $5.628 billion, consolidated adjusted EBITDA of $1.304 billion (up 16.3%), and an adjusted EBITDA margin of 23.2%. Adjusted EPS was $6.12, up 52.2%. Net income available to common shareholders was $826 million and diluted EPS was $9.84. Hospital Operations adjusted EBITDA was $762 million (margin 18.0%, up from 15.6%) and Ambulatory Care adjusted EBITDA was $542 million (margin 39.0%).
What is Tenet Healthcare's full-year 2026 guidance?
Following strong Q2 2026 results, Tenet raised its full-year 2026 adjusted EBITDA guidance to $4.83 to $5.03 billion and raised its adjusted free-cash-flow guidance to $2.725 to $3.025 billion. The board also increased the share-repurchase authorization by $2 billion, reflecting management confidence in cash generation.
How does the Ambulatory Care segment compare to Hospital Operations financially?
In Q2 2026, the Ambulatory Care segment generated $1.388 billion in revenue with a 39.0% adjusted EBITDA margin, while Hospital Operations generated $4.240 billion in revenue with an 18.0% adjusted EBITDA margin. The ambulatory business is structurally more profitable because it attracts a higher commercial payer mix and carries lower fixed costs than acute-care hospitals. The 21-percentage-point margin gap is the central reason Tenet's strategy prioritizes growing the ambulatory platform.
What drove the improvement in Tenet's hospital margins in Q2 2026?
Hospital Operations adjusted EBITDA margin improved to 18.0% in Q2 2026 from 15.6% in the prior-year period, a 240 basis point improvement on $4.240 billion in quarterly revenue. This translates to approximately $100 million in additional quarterly EBITDA relative to the prior-year margin rate. The specific drivers, which may include favorable payer mix, supplemental payment timing, labor-cost moderation, or portfolio restructuring, should be verified through the full quarterly SEC filing and earnings-call transcript for the period.